Table 1.
Pre-operative clinico-radiological factors and incidence of LPLN metastasis
Characteristics | LPLN metastasis positive (N = 9) | LPLN metastasis negative (n = 34) | p value | |
---|---|---|---|---|
Age | < 50 years | 5 (55.5%) | 15 (44.1%) | 0.11 |
≥ 50 years | 4 (45.5%) | 19 (55.9%) | ||
Gender | Male | 3 (33.3%) | 18 (52.9%) | 0.004 |
Female | 6 (67.7%) | 16 (47.1%) | ||
Serum CEA | ≤ 5 ng/mL | 2 (22.2%) | 13 (38.2%) | 0.01 |
> 5 ng/mL | 7 (77.8%) | 21 (61.8%) | ||
Tumour location | R | 6 (66.7%) | 19 (55.9%) | 0.1 |
r | 3 (33.3%) | 15 (44.1%) | ||
Clinical T stage (MRI) | T3 | 3 (33.3%) | 21 (61.8%) | 0.0001 |
T4 | 6 (66.7%) | 13 (38.2%) | ||
Regional lymph nodes | N0 | 3 (33.3%) | 19 (55.9%) | 0.004 |
N1 | 5 (55.5%) | 13 (38.2%) | ||
N2 | 1 (11.2%) | 2 (5.9%) | ||
LPLN on MRI | Not enlarged | 5 (55.5%) | 31 (91.2%) | 0.0001 |
Enlarged < 8 mm short axis | 4 (44.5%) | 3 (8.8%) | ||
Annularity | ≤ 2/3 | 5 (55.5%) | 13 (38.2%) | 0.01 |
> 2/3 | 4 (44.5%) | 21 (61.8%) |
R—tumour left below peritoneal reflation, r—tumour left above peritoneal reflection